aspartic acid has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardalan, B; Jayaram, HN; Johnson, RK | 1 |
| Inokuchi, N; Irie, M; Itagaki, T; Iwama, M; Kobayashi, H; Ogawa, Y; Ohgi, K; Tsuji, T | 1 |
| Harrison, SD; O'Dwyer, PJ; Trader, MW | 1 |
3 other study(ies) available for aspartic acid and Leukemia P388
| Article | Year |
|---|---|
Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Topics: Adenine Phosphoribosyltransferase; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Aspartate Carbamoyltransferase; Aspartic Acid; Carbamoyl-Phosphate Synthase (Ammonia); Drug Resistance; Hypoxanthine Phosphoribosyltransferase; Isoxazoles; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred Strains; Organophosphorus Compounds; Oxazoles; Phosphonoacetic Acid; Purines; Pyrimidines | 1983 |
Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagine/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Arginine; Asparagine; Aspartic Acid; Cell Division; Circular Dichroism; Cloning, Molecular; Escherichia coli; Glutamic Acid; HL-60 Cells; Humans; Lectins; Leukemia P388; Mice; Microscopy, Fluorescence; Mutagenesis, Site-Directed; N-Acetylneuraminic Acid; Rana catesbeiana; Ribonucleases | 2002 |
Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Leukemia P388; Leukemia, Experimental; Mice; Phosphonoacetic Acid; Ribavirin; Ribonucleosides; Thioguanine | 1986 |